EUVIMEDEUVIMED entdecken
Crossref

Novel α‐glucosidase Inhibitors Designed as Type 2 Diabetes Drugs by QSAR, Molecular Docking and Molecular Dynamics Simulation Methods

Jianbo Tong iD, Jing Yan, Yakun Zhang, Xiaoyu Xing

Chemistry & Biodiversity · 2025

DOI: 10.1002/cbdv.202401674 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemistry & Biodiversity, 2025. Verfasst von Jianbo Tong und 3 weiteren Autor:innen. Beteiligte Einrichtung: College of Chemistry and Chemical Engineering, Shaanxi University of Science and Technology, Xi'an, 710021, China. Hauptthemen laut MEDLINE: Glycoside Hydrolase Inhibitors, Quantitative Structure-Activity Relationship, Molecular Docking Simulation, Diabetes Mellitus, Type 2. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diabetes mellitus is a globally prevalent disease of significant concern. Alpha‐glucosidase has emerged as a prominent target for the treatment of type 2 diabetes. In this study, 39 α‐glucosidase inhibitors (AGIs) of tetrahydrobenzo[b]thiophene‐2‐ylurea derivatives to establish a stable and valid Topomer CoMFA model, with a cross‐validation coefficient ( q 2 ) of 0.766 and a non‐cross‐validation coefficient ( r 2 ) of 0.960. Subsequently, the ZINC15 database was used to screen the fragments, based on which 13 novel inhibitor molecules with theoretically potentially high activity were designed. Molecular docking and molecular dynamics simulations to understand the binding status of the inhibitor molecules to the target proteins showed that amino acids ASP215, GLN279 and ARG442 may form hydrogen bonds with the ligands and therefore enhance the inhibitory effect of the small molecules. Additionally, MM/PBSA calculations indicate that the newly designed molecules exhibit more stable binding modes. These molecules also demonstrate favorable ADMET properties with potential as AGIs. The findings would provide valuable guidance and a theoretical foundation for the design and development of novel AGIs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Glycoside Hydrolase InhibitorsQuantitative Structure-Activity RelationshipMolecular Docking SimulationDiabetes Mellitus, Type 2Molecular Dynamics Simulationalpha-GlucosidasesHumansHypoglycemic AgentsDrug DesignMolecular Structure

Stichwörter der Autor:innen

AGIsMM/PBSAMolecular dockingMolecular dynamics simulation

Substanzen

Glycoside Hydrolase Inhibitorsalpha-GlucosidasesHypoglycemic Agents

Autor:innen und Institutionen

  • College of Chemistry and Chemical Engineering, Shaanxi University of Science and Technology, Xi'an, 710021, China.
  • Shaanxi Key Laboratory of Chemical Additives for Industry, Xi'an, 710021, China.

ORCID-Profile: Jianbo Tong

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Tong, J., Yan, J., Zhang, Y., & Xing, X. (2025). Novel α‐glucosidase Inhibitors Designed as Type 2 Diabetes Drugs by QSAR, Molecular Docking and Molecular Dynamics Simulation Methods. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.202401674

Vancouver

Tong J, Yan J, Zhang Y, Xing X. Novel α‐glucosidase Inhibitors Designed as Type 2 Diabetes Drugs by QSAR, Molecular Docking and Molecular Dynamics Simulation Methods. Chemistry & Biodiversity. 2025. doi:10.1002/cbdv.202401674

BibTeX
@article{Tong2025,
  author = {Tong, Jianbo and Yan, Jing and Zhang, Yakun and Xing, Xiaoyu},
  title = {Novel α‐glucosidase Inhibitors Designed as Type 2 Diabetes Drugs by QSAR, Molecular Docking and Molecular Dynamics Simulation Methods},
  journal = {Chemistry & Biodiversity},
  year = {2025},
  doi = {10.1002/cbdv.202401674}
}
Kostenlos starten →